|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
PSTX | Spear Matthew A. | Chief Medical Officer | Dec 06 | Option Exercise | 1.32 | 10,000 | 13,220 | 61,485 | Dec 08 08:38 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Sep 09 | Option Exercise | 1.32 | 10,000 | 13,220 | 51,485 | Sep 10 04:19 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Aug 20 | Option Exercise | 1.32 | 4,000 | 5,288 | 45,485 | Aug 24 05:12 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Aug 20 | Sale | 8.79 | 4,000 | 35,142 | 41,485 | Aug 24 05:12 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Jul 28 | Option Exercise | 1.32 | 20,000 | 26,440 | 41,485 | Jul 30 04:29 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Jun 17 | Option Exercise | 1.32 | 5,000 | 6,610 | 21,485 | Jun 21 08:02 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Jun 11 | Option Exercise | 1.32 | 4,000 | 5,288 | 20,485 | Jun 14 06:18 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Jun 11 | Sale | 9.44 | 4,000 | 37,747 | 16,485 | Jun 14 06:18 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Apr 21 | Option Exercise | 1.32 | 4,000 | 5,288 | 15,485 | Apr 23 08:49 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Apr 23 | Option Exercise | 1.32 | 5,000 | 6,610 | 16,485 | Apr 23 08:49 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Apr 21 | Sale | 8.44 | 4,000 | 33,752 | 11,485 | Apr 23 08:49 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Jan 15 | Option Exercise | 1.32 | 7,564 | 10,000 | 11,485 | Jan 19 05:00 PM |
PSTX | Spear Matthew A. | Chief Medical Officer | Jan 08 | Option Exercise | 1.32 | 3,921 | 5,184 | 3,921 | Jan 11 05:00 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite